Factors affecting improvement after intravenous administration of recombinant tissue plasminogen activator (rtPA) among patients with acute ischemic stroke: A historical cohort study

• Hauptverfasser: Seyed mohammad Masood Hojjati (Verfasst von), Amir Hossein Hasanpour (Verfasst von), Hoda Naghshineh (Verfasst von), Ali Alizadeh khatir (Verfasst von), Payam Saadat (Verfasst von), Fatemeh Sahebian (Verfasst von), Rahele Mehraeen (Verfasst von), Hoda Shirafkan (Verfasst von)
• Format: Buch
• Veröffentlicht: Babol University of Medical Sciences, 2024-02-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background: One of the most effective treatments for patients with acute ischemic stroke (AIS) is intravenous recombinant tissue plasminogen activator (rtPA) which can minimize mortality and morbidities. In this historical cohort study, we investigate the factors affecting clinical outcomes after IV...